Resilience Behavioral Health

Resilience Behavioral Health in Everett, Washington offers Spravato, an FDA-approved esketamine nasal spray for adults with treatment-resistant depression and major depressive disorder with acute suicidal ideation. Administered under licensed medical staff, Spravato activates NMDA receptors in the brain to deliver rapid relief, with noticeable improvement in as little as 24 hours in clinical studies.

All treatments are provided in a certified clinical facility, where patients self-administer the nasal spray and are monitored for at least two hours afterward. Treatment begins with twice-weekly induction sessions for the first four weeks, transitioning to weekly maintenance and then an ongoing schedule based on each patient's needs.

The clinic focuses exclusively on FDA-approved therapies rather than off-label ketamine, offering a calming, home-like environment, collaborative care with existing providers, and full insurance support.